Cargando…
SUN-039 Estradiol Dose and Concentrations in Transfeminine Individuals
Background: Feminizing hormone therapy with estradiol is used to align an individual’s physical characteristics with their gender identity. Australian expert consensus guidelines (1) recommend targeting estradiol concentrations of 250-600 pmol/L (68-163 pg/mL) based on local cross-sectional data (2)...
Autores principales: | Nolan, Brendan J, Brownhill, Adam, Bretherton, Ingrid, Wong, Peggy, Fox, Susan, Locke, Peter, Russell, Nicholas D, Grossmann, Mathis, Zajac, Jeffrey D, Cheung, Ada S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208259/ http://dx.doi.org/10.1210/jendso/bvaa046.877 |
Ejemplares similares
-
Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy
por: Nolan, Brendan J., et al.
Publicado: (2020) -
SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020) -
LBODP089 Effects Of Low-dose Oral Micronised Progesterone On Sleep, Psychological Distress And Breast Development In Transgender Individuals Undergoing Feminising Hormone Therapy: A Prospective Controlled Study
por: Nolan, Brendan J, et al.
Publicado: (2022) -
Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia
por: Balcerek, Matthew I., et al.
Publicado: (2021) -
SUN-LB039 Novel Use of Thromboelastography (TEG) to Investigate the Prothrombotic Effects of Testosterone Replacement Therapy (TRT) for Androgen Deficiency (AD) Established with Diagnostic Rigor (DR)
por: Subramaniam, Shreya, et al.
Publicado: (2019)